NASDAQ:GILD
$77.09
(
-0.721%
)
Friday, 26th May 2023
Gilead Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $76.26 | $84.42 | Friday, 26th May 2023 GILD stock ended at $77.09. This is 0.721% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 2.08% from a day low at $77.02 to a day high of $78.62. |
| 90 days | $76.26 | $87.37 | |
| 52 weeks | $57.17 | $89.74 |
Historical Gilead Sciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $77.16 | $78.62 | $77.02 | $77.09 | 4 840 852 |
| 2023-05-25 | $77.47 | $78.18 | $76.26 | $77.65 | 6 812 395 |
| 2023-05-24 | $79.12 | $79.26 | $78.14 | $79.05 | 5 850 989 |
| 2023-05-23 | $78.60 | $79.56 | $78.10 | $78.58 | 4 296 539 |
| 2023-05-22 | $79.30 | $79.85 | $78.40 | $78.62 | 3 391 603 |
| 2023-05-19 | $78.78 | $79.62 | $78.65 | $78.85 | 5 403 700 |
| 2023-05-18 | $78.88 | $79.05 | $77.37 | $78.21 | 4 911 200 |
| 2023-05-17 | $78.15 | $79.02 | $77.05 | $78.81 | 5 212 531 |
| 2023-05-16 | $79.77 | $79.77 | $78.16 | $78.32 | 5 614 292 |
| 2023-05-15 | $78.07 | $78.40 | $77.83 | $78.38 | 2 612 089 |
| 2023-05-12 | $78.77 | $79.08 | $77.91 | $78.17 | 3 517 556 |
| 2023-05-11 | $78.16 | $78.76 | $77.45 | $78.70 | 4 927 777 |
| 2023-05-10 | $78.77 | $78.84 | $77.17 | $78.11 | 4 926 972 |
| 2023-05-09 | $78.31 | $79.28 | $78.31 | $78.80 | 4 546 123 |
| 2023-05-08 | $79.61 | $79.63 | $78.13 | $78.59 | 3 721 002 |
| 2023-05-05 | $78.75 | $79.83 | $78.22 | $79.75 | 4 047 520 |
| 2023-05-04 | $79.61 | $79.68 | $78.41 | $78.52 | 4 254 448 |
| 2023-05-03 | $80.49 | $80.90 | $79.13 | $79.45 | 4 900 321 |
| 2023-05-02 | $81.53 | $82.04 | $80.09 | $80.44 | 5 374 701 |
| 2023-05-01 | $82.47 | $82.55 | $81.20 | $81.42 | 5 207 180 |
| 2023-04-28 | $82.52 | $82.85 | $80.08 | $82.21 | 10 409 964 |
| 2023-04-27 | $83.74 | $83.86 | $82.42 | $83.55 | 8 238 774 |
| 2023-04-26 | $84.24 | $84.42 | $82.90 | $83.74 | 4 227 400 |
| 2023-04-25 | $86.95 | $87.08 | $85.50 | $85.59 | 5 225 581 |
| 2023-04-24 | $86.62 | $87.37 | $86.49 | $86.70 | 5 788 941 |
| 2023-04-21 | $84.87 | $86.88 | $84.75 | $86.57 | 8 038 998 |
| 2023-04-20 | $83.75 | $84.88 | $83.70 | $84.69 | 5 927 713 |
| 2023-04-19 | $83.46 | $84.31 | $83.39 | $84.11 | 3 111 889 |
| 2023-04-18 | $83.74 | $83.93 | $82.97 | $83.78 | 4 283 789 |
| 2023-04-17 | $83.41 | $83.74 | $83.03 | $83.63 | 4 442 873 |
| 2023-04-14 | $83.03 | $83.24 | $81.98 | $83.00 | 4 885 491 |
| 2023-04-13 | $81.96 | $83.34 | $81.93 | $83.27 | 4 223 081 |
| 2023-04-12 | $82.97 | $83.24 | $81.74 | $82.16 | 5 145 991 |
| 2023-04-11 | $82.56 | $83.11 | $82.26 | $82.54 | 3 668 511 |
| 2023-04-10 | $83.50 | $83.50 | $82.32 | $82.60 | 3 563 815 |
| 2023-04-06 | $84.07 | $84.83 | $83.26 | $83.37 | 3 724 871 |
| 2023-04-05 | $82.30 | $83.72 | $81.95 | $83.65 | 4 614 977 |
| 2023-04-04 | $83.16 | $83.45 | $81.82 | $82.12 | 4 490 598 |
| 2023-04-03 | $82.94 | $83.80 | $82.64 | $83.24 | 5 082 073 |
| 2023-03-31 | $81.64 | $83.14 | $81.19 | $82.97 | 7 135 555 |
| 2023-03-30 | $81.78 | $81.90 | $81.06 | $81.45 | 3 822 761 |
| 2023-03-29 | $81.26 | $81.97 | $80.93 | $81.29 | 5 469 272 |
| 2023-03-28 | $79.96 | $81.11 | $79.79 | $80.97 | 4 154 848 |
| 2023-03-27 | $80.38 | $80.99 | $79.41 | $79.58 | 4 444 905 |
| 2023-03-24 | $78.93 | $80.40 | $78.33 | $80.00 | 4 805 534 |
| 2023-03-23 | $77.78 | $78.93 | $77.64 | $78.76 | 5 015 561 |
| 2023-03-22 | $79.10 | $79.38 | $77.76 | $77.81 | 4 908 875 |
| 2023-03-21 | $79.53 | $80.05 | $78.36 | $79.14 | 4 744 674 |
| 2023-03-20 | $77.71 | $79.68 | $77.63 | $79.46 | 4 672 644 |
| 2023-03-17 | $79.76 | $79.76 | $76.53 | $77.31 | 16 827 096 |
About Gilead Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
